The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

AIMS: To assess whether renal impairment influences the pharmacokinetics of ziprasidone, and to determine whether ziprasidone is cleared via haemodialysis. METHODS: Thirty-nine subjects with varying degrees of renal impairment were enrolled into an open-label, multicentre, multiple-dose study and as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aweeka, F, Jayesekara, D, Horton, M, Swan, S, Lambrecht, L, Wilner, K D, Sherwood, J, Anziano, R J, Smolarek, T A, Turncliff, R Z
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2000
Matèries:
Supplement
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2015058/
https://ncbi.nlm.nih.gov/pubmed/10771451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2000.00150.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars